Market Overview

Defiance ETFs Names Former BlackRock Executive Paul Dellaquila as Global Head of ETFs; Dr. Tom Bowles as Director of Research

Share:

Mr. Dellaquila has close to 20 years of distribution experience, with
the last decade focused on the world of ETFs

Dr. Bowles is a recognized pioneer in the research and implementation
of artificial intelligence and machine learning approaches

Defiance
ETFs
today announced the addition of two senior members to its
growing team.

Paul Dellaquila, CIMA, CAIA, has been named Global Head of ETFs, and Dr.
Tom Bowles, PhD, has been named Director of Research for the firm.

In his new role, Mr. Dellaquila will be in charge of distribution and
product development for Defiance ETFs. For the past six years, he was a
leader of U.S. Wealth Advisory ETF distribution for BlackRock and was
formerly head of iShares Private Group sales desk. In his previous role,
he was responsible for iShares ETF distribution efforts across the
wirehouse, independent and private wealth channels. Mr. Dellaquila has
also held senior roles overseeing BlackRock open end, SMA and iShares
distribution for the wirehouse channel.

"Paul's client-centric approach and deep knowledge of portfolio
construction and the ETF industry make him ideally suited to take on
this role with Defiance," said Matthew Bielski, founder and CEO of
Defiance ETFs.

Dr. Bowles, Defiance ETFs' incoming Director of Research, is one of the
world's most accomplished experts in the fields of machine learning,
quantum computing and artificial intelligence (AI). Through his
pioneering work in utilizing alternative data, such as that gathered
from satellites, news and social feeds, Dr. Bowles helped create a
number of first of their kind applications for these disruptive
technologies. He also serves as the founder in residence and chief
scientist at Founder's Factor and Founders Forum, a network of
successful startup founders and business leaders, and holds a Degree in
Mathematics and Computing, and a PhD from the University of Oxford in
Clinical Medicine.

"Defiance's mission is to provide investors with targeted portfolios
that allow them to access transformative technologies, and there is
perhaps no one better at identifying truly transformative technology
than Dr. Bowles," said Bielski. "We are thrilled to have him join our
team and head up our research efforts as we look to continue to grow our
family of ETFs."

These additions to the Defiance leadership team come shortly after the
launch of the firm's first Exchange Traded Fund (ETF), Defiance
Future Tech ETF
(NYSE:AUGR), which is designed for investors
seeking to capitalize on the growing opportunities in augmented reality
and virtual reality (AR/VR) technology, a disruptive tech category that
is already having a meaningful impact on a wide range of industries.

The firm has also filed for a number of other ETFs, also focused on
disruptive technology categories.

About Defiance ETFs

Defiance ETFs offers investors access to transformative technology via
targeted portfolios. Defiance ETFs' distinct approach to disruptive
investing empowers investors to be on the leading edge of technological
developments that have the potential to alter industries, and change how
we experience the world. The firm's flagship product, AUGR, focuses on
the opportunities presented by augmented and virtual reality.

The Funds' investment objectives, risks, charges, and expenses must
be considered carefully before.
The prospectus and summary
prospectus contains this and other important information about the
investment company.
The prospectus can be obtained by calling
1-833-333-9383.
Please read it carefully before investing.

Investing involves risk. Principal loss is possible. As
an ETF, the fund may trade at a premium or discount to NAV.
Shares
of any ETF are bought and sold at market price (not NAV) and are not
individually redeemed from the Fund.
The Fund is not actively
managed and would not sell a security due to current or projected under
performance unless that security is removed from the Index or is
required upon a reconstitution of the Index. A portfolio concentrated in
a single industry or country, may be subject to a higher degree of risk.

The value of stocks of information technology companies are
particularly vulnerable to rapid changes in technology product cycles,
rapid product obsolescence, government regulation and competition.
The
Fund is considered to be non-diversified, so it may invest more of its
assets in the securities of a single issuer or a smaller number of
issuers.
Investments in foreign securities involve certain risks
including risk of loss due to foreign currency fluctuations or to
political or economic instability.
This risk is magnified in
emerging markets.
Small and mid-cap companies are subject to
greater and more unpredictable price changes than securities of
large-cap companies.

The BlueStar Augmented and Virtual Reality Index is a rules-based index
tracking the performance of a group of globally-listed stocks of
companies engaged in the research & development or commercialization of
products and services related to augmented and virtual reality within
one of the following categories: Gaming systems and video games;
artificial intelligence, including machine vision and natural language
processing; graphic processing units; cloud computing infrastructure;
simultaneous localization and mapping; displays including holographic
and adaptive interfaces; and sensors for depth perception and
positioning. It is not possible to invest directly in an index.

The "BlueStar Augmented and Virtual Reality Index™" and "BAUGTR™ Index"
(collectively "Augmented and Virtual Reality Index"), is the exclusive
property and a trademark of BlueStar Global Investors LLC d/b/a BlueStar
Indexes® and has been licensed for use for certain purposes by Defiance
ETFs LLC. Products based on the Augmented and Virtual Reality Index are
not sponsored, endorsed, sold or promoted by BlueStar Global Investors,
LLC or BlueStar Indexes®, and BlueStar Global Investors, LLC and
BlueStar Indexes® makes no representation regarding the advisability of
trading in such product(s).

Defiance ETFs, LLC is the adviser to the Fund which is distributed by
Quasar Distributors, LLC.

View Comments and Join the Discussion!